Want to Calculate Fair Value?
Enter Stock | Calculate Fair Value
Stock: BMRN
Book Value Per Share: $30.21
EPS: $5.025
Diluted EPS TTM: $2.7
Dividend Per Share: None
Dividend Yield: 0.00 %
Dividend Payout Ratio: 0%
Price To Sales Ratio TTM: 3.655
Price To Book Ratio: 1.861
PEG Ratio: 0.806
EV To EBITDA: 13.01
P/E Ratio: 20.82
Forward P/E Ratio: 13.3
Ex Dividend Date: None
Dividend Date: None
Current Price: $56.62
Previous Close: $58.23
52 Week Low: $52.93
52 Week High: $94.85
Earning Date (within 30 days): 2025-08-05
50 Day MA: $59.32
200 Day MA: $66.68
Link to Yahoo (Financial): BMRN

Advertisement
 
* Note: Prices are in Million (M) USD.
Description:
Biomarin Pharmaceutical Inc (BMRN) ↓
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
These criteria used Company's Cash, EBITDA and Debt balance to determines its fair value:
Cash : $943 M
Debt : $595 M
EBITDA : $807 M

Since Cash is greater than Total Debt, 5 points assigned.
This criteria used industry in which company operates:
Sector: Healthcare
Industry: Biotechnology

Based on industry, 5 points assigned.
This criteria used Company's Price To Earning (P/E) Ratio to determines its fair value:
Forward PE Ratio: 11.27

Since Forward PE Ratio is less than 15, 5 points assigned.
This criteria used Company's ability to convert Sales into free cash flow to determine fair value:
Average Free Cash Flow: $98 M
Average Revenue: $1,053 M
Revenue Converted To Free Cash FLow(%): 9%
Avg Free Cash Flow Growth Per Year (Last 5 Years): 254.18%

Since Free Cash Flow (FCF) to Revenue percentage is less than 15, 1 point assigned.
This criteria used company's growth potential to calculate its fair value:
Latest Revenue (2024-12-31): $2,854 M
Revenue 4 Years Ago (2020-12-31): $1,860 M
Last 5 Years Average Revenue Growth: 11%

Since Revenue Growth is between 10 - 15, 3 points assigned.
This criteria used Company's ability to buy back its own share:
Latest Share Count (2024-12-31): $197 M
Share Count 5 Years Ago (2020-12-31): $192 M

Company is not buying back its own shares, 0 points assigned.
This criteria used Company's dividend payout ratio to determine its fair value:
Next Year Earnings Per Share (EPS): $5.57
Trailing 12-Month Earnings Per Share (EPS): $4.48
Average Earnings Per Share (EPS): $5.03
Dividend Per Share (DPS): $0
Payout Ratio: 0%
Dividend Yield: 0%

Since Dividend Per Share is less than or equal to 0, 0 point assigned.

Since Dividend Yield is less than 1, 0 point assigned.
This criteria used Company's Return On Equity (ROE%) to determine its fair value:
Average ROE: -2%

Since Average ROE is negative, 0 point assigned.
This criteria used Company's current price to its 52 week low price to determines its fair value:
Current Price: $57
52-Week Low: $53
Threshold Price (15% Above 52-Week Low): $61

Since Current price is within 15% threshold, 5 points assigned.
This criteria used Company's Market Cap to determines its fair value:
Market Capitalization: $10,782 M

Since Market Cap is between 10B - 100B, 2 points assigned.
% Exposure to Total Portfolio
Based on the calculated score, we recommend do not exceed 3% exposure of Total Portfolio.
Value-Trade has assigned 26 points to above Biomarin Pharmaceutical Inc (BMRN) stock.
Last 7 Years Avg PE (Limited to last 7 years of EPS data) 39, Fair Value PE 25, Industry Based PE is 20 and Growth based PE is 10. Based on these all values average assigned is 23.50.
Value-Trades has assined P/E value 23.50. Since an average (Current Year EPS + Next Year EPS) earning per share is $5.025.
The fair value of Biomarin Pharmaceutical Inc (BMRN) stock should be (23.50 x $5.025) = $118.09

Share this valuation:



Advertisement

Advertisement